Blog

MariTide Review- Overview MariTide, also known as maridebart cafraglutide (developmental name AMG 133), is an investigational weight loss developed by […]

Survodutide Review- Overview Survodutide is a dual agonist of the glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R), aimed at

Mazdutide Review – Overview Mazdutide is a dual agonist of the glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR). It

Ecnoglutide Review- Overview Ecnoglutide (XW003) is a New, long-acting GLP-1 analog being developed primarily for the treatment of type 2

CagriSema Review– Overview CagriSema is an investigational medication developed by Novo Nordisk, combining Semaglutide and Cagrilintide for the treatment of

Retatrutide Review– Overview Retatrutide is an investigational drug developed by Eli Lilly and Company. It is a triple hormone receptor

Oral Amycretin Review- Overview Oral Amycretin is an experimental weight loss medication developed by Novo Nordisk. It has shown promising

Danuglipron Review- Overview Danuglipron is an investigational oral medication developed by Pfizer. It is a small molecule glucagon-like peptide-1 receptor

Orforglipron Review- Overview Orforglipron is an oral nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in development primarily for the treatment of

Oral Semaglutide Weight Loss Reviews: Overview Oral Semaglutide, marketed under the brand name Rybelsus, is the first glucagon-like peptide-1 (GLP-1) receptor